Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

about

Current perspectives in bladder cancer management Photochemical internalization in bladder cancer - development of an orthotopic in vivo model.

P2860

Q26824914-1F508FDA-E748-45D3-A49E-E82BFF35A445 Q48642623-B990D211-178C-4FD1-B0FF-59778C3AD6D3

P2860

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

Item

http://www.wikidata.org/entity/Q36973553

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

@en

type

Item

label

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

@en

prefLabel

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

@en

P1476

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

@en

P2093

Kirk A Keegan

http://www.w3.org/2001/XMLSchema#string

Matthew J Resnick

http://www.w3.org/2001/XMLSchema#string

Peter E Clark

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.

Genomic and personalized medicine: foundations and applications.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy.

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.

P304

278-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCO.0B013E3283510587

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22273550

http://www.w3.org/2001/XMLSchema#string

P932

3698482

http://www.w3.org/2001/XMLSchema#string

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

about

P2860

P2860

Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932